Pilot Study of Low-Dose, Divided Maximum Tolerated Dose of CPT-11 in 21 Consecutive Patients with Metastatic Colorectal or Gastric Cancer

By Takahashi Yutaka   Kitakata Hidekazu   Yamashita Kaname   Yasumoto Kazuo   Omote Kazuhiko   Minamoto Toshinari   Mai Masayoshi  

Surgery Today, Vol. 34, Iss. 3, 2004-03 ,pp. : 246-250

Springer Publishing Company

Access to resources Recommend Favorite

Double primary malignancy in colorectal cancer patients—MSI is the useful marker for predicting double primary tumors

By Yun H.   Yi L.   Cho Y.   Park J.   Cho Y.   Yun S.   Kim H.   Chun H.   Lee W.  

International Journal of Colorectal Disease, Vol. 24, Iss. 4, 2009-04 ,pp. : 369-375

Springer Publishing Company

Access to resources Recommend Favorite

Lipid Peroxidation as Additional Marker in Patients with Colorectal Cancer

By  

European Surgical Research, Vol. 34, Iss. 5, 2002-09 ,pp. : 346-350

Karger

Access to resources Recommend Favorite

Deleted in Colorectal Cancer Protein Expression as a Possible Predictor of Response to Adjuvant Chemotherapy in Colorectal Cancer Patients

By Gal Rivka   Sadikov Evgeny   Sulkes Jaqueline   Klein Baruch   Koren Rumelia  

Diseases of the Colon & Rectum, Vol. 47, Iss. 7, 2004-07 ,pp. : 1216-1224

Springer Publishing Company

Access to resources Recommend Favorite

Detection of Occult Metastasis in Lymph Nodes From Colorectal Cancer Patients: A Multiple-Marker Reverse Transcriptase-Polymerase Chain Reaction Study

By Chen Gong   McIver Cassandra M.   Texler M.   Lloyd Julia M.   Rieger Nicholas   Hewett Peter J.   sen Wan De   Hardingham Jennifer E.  

Diseases of the Colon & Rectum, Vol. 47, Iss. 5, 2004-05 ,pp. : 679-686

Springer Publishing Company

Access to resources Recommend Favorite